Johnson & Johnson

Key figures

Period 2024-12-30 to 2025-12-28ConsolidatedU.S. GAAP

RevenueDisclosed US$94.2B

Operating marginCalculated Could not be retrieved

Net assets to total assetsCalculated Could not be retrieved

Company profile

Ticker JNJ / CIK 200406 / Chemicals and pharmaceuticals (SIC 2834) / Fiscal year end 2025-12-28
U.S. GAAP. From the Form 10-K filed with the SEC’s EDGAR.

Tables scroll sideways

Disclosed data

Source: U.S. SEC annual report (Form 10-K) (2024-12-30 to 2025-12-28) · filed 2026-02-11

Profitability Could not be retrieved

Growth (revenue, 4-year average) ★★★☆☆position among all companies 4.6%

Capital efficiency Could not be retrieved

Revenue and profit

Performance, financial position and capital allocation

Johnson & Johnson

Recent performance trends

Johnson & Johnson

Cash flow trends

Consolidated indicators (7 items)

Item	4 years ago	3 years ago	2 years ago	Last year	This year
Net sales	US$78.7 billion	US$80.0 billion	US$85.2 billion	US$88.8 billion	US$94.2 billion
Net income	US$20.9 billion	US$17.9 billion	US$35.2 billion	US$14.1 billion	US$26.8 billion
Total assets	US$182.0 billion	US$187.4 billion	US$167.6 billion	US$180.1 billion	US$199.2 billion
Net cash provided by (used in) operating activities	US$23.4 billion	US$21.2 billion	US$22.8 billion	US$24.3 billion	US$24.5 billion
Net cash provided by (used in) investing activities	US$-8.7 billion	US$-12.4 billion	US$0.9 billion	US$-18.6 billion	US$-23.6 billion
Net cash provided by (used in) financing activities	US$-14.0 billion	US$-8.9 billion	US$-15.8 billion	US$-3.1 billion	US$-5.5 billion
Cash and cash equivalents	US$14.5 billion	US$12.9 billion	US$21.9 billion	US$24.1 billion	US$19.7 billion

Revenue scale in the same industry

Johnson & Johnson

Chemicals and pharmaceuticals: 56 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed

1 Johnson & JohnsonThis companyFY Dec 2025 US$94.2B
2 Procter & GambleFY Jun 2026 US$87.0B
3 ELI Lilly ANDFY Dec 2025 US$65.2B
… 53 companies

Sources and methodology

Basic indicators

Item	Value	Consolidated / Non-consolidated	Source
Purchase of property, plant and equipment	US$4.8 billion	Consolidated	Disclosed
Cash and cash equivalents	US$19.7 billion	Consolidated	Disclosed
Net cash provided by (used in) financing activities	US$-5.5 billion	Consolidated	Disclosed
Net cash provided by (used in) investing activities	US$-23.6 billion	Consolidated	Disclosed
Net cash provided by (used in) operating activities	US$24.5 billion	Consolidated	Disclosed
Depreciation and amortization	US$7.5 billion	Consolidated	Disclosed
Stockholders' equity (including non-controlling interests)	US$81.5 billion	Consolidated	Disclosed
Net sales	US$94.2 billion	Consolidated	Disclosed
Net income	US$26.8 billion	Consolidated	Disclosed
Total assets	US$199.2 billion	Consolidated	Disclosed
Purchase of treasury stock	US$6.0 billion	Consolidated	Disclosed
Operating margin	Cannot be calculated	Not applicable	Not calculated (no operating income in this year's 10-K)
Net assets to total assets	Cannot be calculated	Not applicable	Not calculated (no stockholders' equity in this year's 10-K)
Net margin	28.5%	Consolidated	Calculated
Return on equity	Cannot be calculated	Not applicable	Not calculated (no stockholders' equity in this year's 10-K)

How to read the figures, and caveats

Terms

Consolidated: the parent company together with the subsidiaries it consolidates
Parent-only: the single company that filed the annual securities report
Calculated: a disclosed figure put through the formula shown
Not disclosed: no such value in the filing (not treated as zero)
Not retrieved: a value this page could not extract, including values in the filing that could not be matched. The same item may appear in another table
Segment: a business division the company uses in its disclosures
Industry median: the middle value among companies in the same industry that disclose the item
★: position when every company is lined up by value (not a judgement of the company)See the formulas
Source: document name, period covered, filing date and where it was obtained
Tables scroll sideways

Key figures

Net margin 28.5%　Net income ÷ revenue 　＝ US$26.8 billion ÷ US$94.2 billion

Cash flow trends

Cash flow (change in cash and cash equivalents) by activity. Operating CF: cash generated by the business. Investing CF: asset purchases, disposals and acquisitions. Financing CF: borrowing, repayments, dividends and share repurchases. Negative: net outflow

Revenue scale in the same industry

Revenue (disclosed values) of companies in the same industry, using the same grouping as the industry pages. Only the top three and the two companies either side of this one. Bar length relative to the largest company (100). An order of size, not a ranking of quality

Data sources and calculation methods

Primary source: the SEC’s EDGAR: Form 10-K of Johnson & Johnson (CIK 200406), free to read
Accounting standard: U.S. GAAP / Form: 10-K / Filed: 2026-02-11 / Accession number: 0000200406-26-000016

Amounts: machine transcription of XBRL filed with the SEC’s EDGAR (bulk companyfacts), no manual re-keying. In dollars, not converted to yen (an exchange rate would produce a figure that was never disclosed)
Annual values: full-year figures in the Form 10-K only. Where a restatement gives more than one value for a period, the more recently filed one. Each five-year series from a single element (tag)
Revenue: the company’s elements checked in the order Revenues → RevenueFromContractWithCustomer… → SalesRevenueNet, taking the one with the most recent period. What “revenue” covers may differ between companies
Net income: attributable to the parent’s shareholders. Stockholders’ equity: excluding non-controlling interests (the figure including them on a separate row)
★: position of values calculated from disclosed figures among U.S. companies, on a five-step scale. Separate from Japanese companies because of different accounting standards. Finance (SIC 6000s) in its own set, as revenue is defined differently
Equity-to-asset ratio: no rank (higher or lower is not better or worse). Calculated here as stockholders’ equity ÷ total assets, as U.S. companies do not disclose it (for Japanese companies the field is the company’s disclosed value). Return on equity also calculated here
Industry: first two digits of the SEC’s SIC code. A different classification from the Japanese industry categories (FSA), so shown separately from Japanese companies
Segment breakdown, profit-and-loss flow and cost breakdown: not published (bulk companyfacts holds company-wide figures only). Nothing drawn from guesswork
Share prices: not used. Employee counts: only where the 10-K XBRL carries them as a number